Effect of COVID-19 on mortality due to diabetes mellitus in Brazil: A time series analysis from 2010 to 2023
Larissa Otaviano Mesquita, Debora França dos Santos, Kenia Mara Baiocchi de Carvalho

TL;DR
This study examines how the COVID-19 pandemic affected diabetes-related deaths in Brazil from 2010 to 2023, finding that mortality trends shifted after 2020.
Contribution
The study provides new insights into how the pandemic altered diabetes mortality trends in Brazil using time series analysis.
Findings
Diabetes-related mortality rates decreased before the pandemic but became stationary during the pandemic period.
The Northeastern region had the highest mortality rates, and the trend shifted from decreasing to stationary after 2020.
Mortality trends for older adults and specific regions stabilized during the pandemic, indicating potential disruptions in healthcare.
Abstract
Diabetes mellitus (DM) is a major global public health concern, particularly in Brazil. This study aimed to analyze DM-related mortality trends before and during the pandemic to assess the possible influence of the COVID-19 pandemic on DM mortality in Brazil. Mortality was assessed using standardized mortality rates stratified by age group (20–29 years, 30–49 years, 50–69 years, 70 years or older), sex (male, female), and geographic region (North, Northeast, Southeast, South, and Midwest). Mortality rates were calculated using the Brazilian Mortality Information System and official national population estimates. An analytical ecological time series analysis was performed using the Prais–Winsten regression model to assess the DM-related mortality trends in two scenarios: before (2010–2019) and including the pandemic period (2010–2023). The annual percentage change (APC) and 95%…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Diabetes, Cardiovascular Risks, and Lipoproteins · Chronic Disease Management Strategies
